ACCELERATE
PHASE 1

How to join Phase 1 trial

WATCH THE VIDEO

ACHIEVEMENT

0
Number of ongoing
Phase 1 trials
0patients
Number of Patients per year
enrolled in phase 1 trials
0
Number of ongoing FIH
phase 1 trials
JOIN US
JOIN US

JOIN US

National Cancer Center Hospital plays a crucial role in anti-cancer drug development. Recently, the new drug development has been getting more globalized to keep up with the worldwide trend.

INFORMATION

2024.04.10
News
Dr. Yuki Katsuya presented a poster at AACR 2024.
2023.10.26
News
Dr. Ryo Sadachi and Dr. Mao Okada presented a poster at ESMO 2023.
2023.09.28
News
Dr. Yuji Uehara, a former resident of our department, and his colleagues’ paper was published in “The ASCO Post”.
2023.09.15
News
Dr. Yuji Uehara, a former resident of our department, and his colleagues’ paper was published in “JAMA Network Open”.
2023.08.07
News
Published profile page for Dr. Mao Okada and Dr. Hirokazu Shoji and Dr. Ryoko Yamasaki.